San Diego-centered Viking Therapeutics marked by itself as a significant competitor during the weight loss drug market place in February right after revealing promising details from the mid-phase demo of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when specified like a weekly injection As well as in